The Spectranetics Corporation (SPNC)
-NasdaqGS 19.60
0.30(1.51%) 1:10PM EDT - Nasdaq Real Time Price
| Prev Close: | 19.90 |
|---|
| Open: | 19.90 |
|---|
| Bid: | 19.54 x 100 |
|---|
| Ask: | 19.55 x 200 |
|---|
| 1y Target Est: | 21.33 |
|---|
| Beta: | 0.97 |
|---|
| Next Earnings Date: | 26-Jul-13 |
|---|
| Day's Range: | 19.52 - 20.00 |
|---|
| 52wk Range: | 9.25 - 20.99 |
|---|
| Volume: | 76,256 |
|---|
| Avg Vol (3m): | 263,279 |
|---|
| Market Cap: | 687.04M |
|---|
| P/E (ttm): | 650.83 |
|---|
| EPS (ttm): | 0.03 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Spectranetics downgraded by Northland CapitalBriefing.com(Mon, May 20)
- SPECTRANETICS CORP FinancialsEDGAR Online Financials(Wed, May 15)
- SPECTRANETICS CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, May 9)
- Spectranetics Finalizes EXCITE ISR Adjunct Analysis PlanGlobeNewswire(Mon, May 6)
- Spectranetics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Over-Allotment OptionGlobeNewswire(Wed, May 1)
- Insiders Bullish on Certain Holdings of IWCat Forbes(Wed, May 1)
- 4 Stocks Rising on Unusual Volumeat TheStreet(Fri, Apr 26)
- SPECTRANETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial StatementsEDGAR Online(Fri, Apr 26)
- Spectranetics Prices Public Offering of Common StockGlobeNewswire(Thu, Apr 25)
- Spectranetics upgraded to Outperform from Market Perform at Barringtonat theflyonthewall.com(Thu, Apr 25)
- Spectranetics' CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, Apr 23)
- The Spectranetics Earnings: Everything You Must Know Nowat Wall St. Cheat Sheet(Tue, Apr 23)
- Spectranetics Announces Common Stock OfferingGlobeNewswire(Tue, Apr 23)
- Spectranetics Achieves First Quarter Revenue of $37.7 MillionGlobeNewswire(Tue, Apr 23)
- SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibiEDGAR Online(Tue, Apr 23)
Key Statistics
| Forward P/E (1 yr): | 139.46 |
|---|
| P/S (ttm): | 4.84 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.02 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.02 |
|---|
| Mean Recommendation*: | 1.5 |
|---|
| PEG Ratio (5 yr expected): | 89.00 |
|---|
Business Summary
The Spectranetics Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive procedures in the cardiovascular system.
View More